Verproside
Names
Biological Activity
[Description]:
Verproside, a catalpol derivative iridoid glycoside isolated from the genus Pseudolysimachion, represses TNF-α -induced MUC5AC expression by inhibiting NF-κB activation via the IKK/IκB signaling cascade. Verproside has potent anti-inflammatory, antioxidant, antinociceptive activities and ir is a potent anti-asthmatic/COPD drug candidate in vivo[1].
[Related Catalog]:
[Target]
[In Vitro]
Verproside (2.5-20 μM; for 2 hours) markedly reduces phosphorylation levels of IKKα/β, IκBα, and TAK1 in the 5-20 μM range[1]. Western Blot Analysis[1] Cell Line: NCI-H292 cells Concentration: 2.5, 5, 10, 20 μM Incubation Time: 2 hours Result: Resulted in markedly reduced phosphorylation levels of IKKα/β, IκBα, and TAK1.
[In Vivo]
Verproside (Intragastrically; 30 mg/kg; 48 hours) significantly reduces the immunoglobulin E (IgE) levels of verproside-treated mice[2]. Animal Model: Specific pathogen-free female BALB/c mice aged 8-10 weeks[2] Dosage: 30 mg/kg Administration: Intragastrically; 48 hours Result: Reduced significantly the immunoglobulin E (IgE) levels.
[References]
Chemical & Physical Properties
[ Density]:
1.75±0.1 g/cm3(Predicted)
[ Boiling Point ]:
822.9±65.0 °C(Predicted)
[ Molecular Formula ]:
C22H26O13
[ Molecular Weight ]:
498.43
[ Storage condition ]:
?20°C
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H319
[ Precautionary Statements ]:
P305 + P351 + P338
[ Hazard Codes ]:
Xi
[ Risk Phrases ]:
36
[ Safety Phrases ]:
26
[ RIDADR ]:
NONH for all modes of transport
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.